Enzymatic Macrolactonization in the Presence of DNA Leading to Triostin A Analogs  by Koketsu, Kento et al.
Chemistry & Biology
ArticleEnzymatic Macrolactonization in the Presence
of DNA Leading to Triostin A Analogs
Kento Koketsu,1 Hiroki Oguri,1,2,* Kenji Watanabe,3 and Hideaki Oikawa1,*
1Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo 060-0810, Japan
2Division of Innovative Research, Creative Research Initiative ‘Sousei’ (CRIS), Hokkaido University, Sapporo 001-0021, Japan
3Department of Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90033, USA
*Correspondence: oguri@sci.hokudai.ac.jp (H.O.), hoik@sci.hokudai.ac.jp (H.O.)
DOI 10.1016/j.chembiol.2008.05.022SUMMARY
Excised thioesterase domains are versatile catalysts
for macrocyclization. However, thioesterase-cata-
lyzed cyclization is often precluded due to the occur-
rence of hydrolysis andproduct inhibition. To circum-
vent these obstacles, we devised an unprecedented
strategy: coincubation with DNA to capture the
cyclic products possessing DNA-binding properties.
In experiments involving echinomycin thioesterase-
catalyzed macrolactonization leading to the cyclic
triostin A analog TANDEM,we found that the addition
of DNA drastically improved the yield of TANDEM
(19%/67%),withacomplete reversal of thecycliza-
tion:hydrolysis ratio (1:2 / 18:1). Furthermore, the
applicability of this protocol was demonstrated for
a variety of substrates. The results described herein
provide insight into the mechanism of echinomycin
thioesterase-catalyzed conversions and also pave
the way for chemoenzymatic synthesis of the quin-
oxaline antibiotics and their analogs.
INTRODUCTION
In nature, a variety of small molecules with rich structural diver-
sity are assembled by modular megaenzymes such as nonribo-
somal peptide synthetases (NRPSs) (Sieber and Marahiel, 2005),
polyketide synthases (PKSs), and NRPS/PKS hybrid systems
(Fischbach and Walsh, 2006). A common structural feature of
medicinally important natural products, including the immuno-
suppressant cyclosporine (NRPS), the antibiotic erythromycin
(PKS), and the antitumor agent epothilone (NRPS/PKS), is a
constrained macrocyclic skeleton. The rigidified cyclic skeleton
allows these compounds to adopt a biologically active confor-
mation for interaction with the dedicated biomacromolecular tar-
get and also increase their stability against proteolytic digestion.
In the biosynthesis of nonribosomal peptides and polyketides,
the macrocyclization step is generally catalyzed by a thioester-
ase (TE) domain embedded at the C terminus of a multidomain
enzymatic assembly line (Kohli and Walsh, 2003). Since con-
struction of the macrocyclic skeleton is intrinsically disfavored
entropically due to the loss of conformational freedom, chemo-
enzymatic approaches with the excised TE domains have been
explored to provide an alternative and efficient method for818 Chemistry & Biology 15, 818–828, August 25, 2008 ª2008 Elsevaccessing macrocyclic natural products in place of conventional
chemical synthesis.
Among the cyclic peptides biosynthesized by NRPSs, some
members having C2- or C3-symmetric cyclic skeletons are
thought to be constructed via oligomerization and subsequent
cyclization (Kohli and Walsh, 2003). Studies on the TE domain
of the iterative enterobaction synthase (EntF) suggested that
the C-terminal TE domain catalyzes not only the cyclization,
but also the ligation, of linear peptides (Shaw-Reid et al., 1999;
Zhou et al., 2006). In a similar fashion, the iterative mechanism
has been assumed for the biosynthesis of gramisidin S (Stoll
et al., 1970; Hori et al., 1989; Kra¨tzschmar et al., 1989), thiocora-
line (Lombo et al., 2006), and valinomycin (Cheng, 2006). Re-
cently, in vitro experimentation with an excised gramicidin TE
(GrsB TE) has deciphered the detailed mechanism of the iterative
TE domain (Hoyer et al., 2007).
Echinomycin (1) is isolated from various species of strepto-
mycete (Dell et al., 1975) and is the best known member of the
quinoxaline/quinoline antibiotic group, which includes triostin A
(2) (Otsuka et al., 1976), SW-163C (Kurosawa et al., 2001), thio-
coraline (Romero et al., 1997), and BE-22179 (Okada et al., 1994)
(Figure 1). The common structural feature of these C2-symmetric
compounds is the crossbridged cyclic octapeptide dilactone
core linked by twin quinoxaline/quinoline 2-carbonyl chromo-
phores (Dawson et al., 2007). Echinomycin (1) shows potent
antitumor activity by inhibition of DNA replication and RNA syn-
thesis. Both 1 and 2 bind strongly to double-stranded DNA by
bisintercalation, in which twin chromophores are inserted into
the duplex sandwiching 50-CG pairs (Warning and Wakelin,
1974; Vandyke and Dervan, 1984; Wang et al., 1984). In contrast,
triostin A tetra-N-demethyl analog (TANDEM, 3) (Ciardelli et al.,
1978) exhibits distinct sequence selectivity for 50-TA steps,
despite the small structural difference between 2 and 3 (Lavesa
and Fox, 2001). In a similar fashion, the structurally related
quinoxaline/quinoline antibiotics show a range of DNA-binding
affinities and sequence selectivities (Dawson et al., 2007; Boger
et al., 2001).
We recently identified the entire gene cluster responsible for
the formation of 1 (Figure 2A) and achieved total biosynthesis
of 1 and 2 inEscherichia coli (Watanabe et al., 2006). During echi-
nomycin biosynthesis, quinoxaline-2-carboxylic acid (QC),
a starter unit of peptide chain elongation, is biosynthesized
from L-tryptophan via a (2S, 3S)-b-hydroxytryptophan interme-
diate (Figure 2B) (Koketsu et al., 2006). Ecm1-mediated adenyla-
tion of QC conducts the loading of the quinoxaline-2-carbonyl
group onto FabC (Schmoock et al., 2005). Subsequent peptideier Ltd All rights reserved
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Enzymatic Macrolactonization with DNAFigure 1. Structures of Selected Quinoxaline/Quinoline Antibioticselongation (D-Ser / L-Ala / N-Me-L-Cys / N-Me-L-Val) is
catalyzed by modular NRPSs (Ecm6 and Ecm7), affording a
PCP-bound tetrapeptidyl thioester intermediate that is then trans-
ferred to a serine residue in the active site of the terminal TE
domain. Without detailing the precise reaction mechanisms, the
TE domain is assumed to mediate dimerization of the tetrapepti-
des on the PCP and TE domains and subsequent macrolactoniza-
tion entailing the release of the octapeptidyl dilactone framework,
4. Oxidation of the twin thiols by Ecm17 forms the disulfide bridge
and produces 2. Finally, the disulfide of 2 is converted into the
thioacetalbridge of echinomycin, 1, via a unique rearrangement
mediated by SAM-dependent methyltransferase (Ecm18).
Here, we report two approaches for chemoenzymatic syn-
thesis employing the excised echinomycin TE domain (Ecm TE)
expressed in E. coli. First, we explored in vitro dimerization-
cyclization of a tetrapeptidyl thioester substrate not only to
gain insight into the reaction mechanism, but also to achieve
chemoenzymatic synthesis of 2. Second, we investigated mac-
rolactonization of octapeptidyl substrates to produce 3 and its
analogs. To suppress hydrolysis of the ester linkages as well
as product inhibition, we developed an unprecedented, to our
knowledge, protocol: coincubation with double-stranded DNA
to capture cyclized products that possess bisintercalating
properties. The efficiency and applicability of Ecm TE-catalyzed
cyclization in the presence of DNA have been demonstrated.
RESULTS
Cloning and Expression of the Ecm TE Domain
An expression plasmid was constructed by subcloning of the
gene fragment encoding the TE domain region of the NRPS
gene (ecm7) into pET22b vector. The border of the Ecm TE do-
main of Ecm7 was defined on the basis of alignment with the
characterized TE domains tyrocidine TE, surfactin TE, gramicidin
TE, and calcium-dependent antibiotic CDA3 TE (Trauger et al.,
2000; Kohli et al., 2001; Grunewald et al., 2004) (see Figure S1Chemistry & Biology 15, 8available online). The recombinant Ecm TE was successfully
expressed in E. coli BL21 (DE3) at 24C as a soluble protein
and was purified by Ni-chelating affinity chromatography. The
recombinant protein was obtained with a yield of 18 mg/l.
SDS-PAGE analysis indicated that the protein purity was
>95% (Figure S2).
Ecm TE-Mediated Conversion of Tetrapeptidyl-SNAC
Substrate 5 to Triostin A, 2
To explore the potential of the excised Ecm TE domain to cata-
lyze dimerization of the tetrapeptidyl linear substrate and subse-
quent lactonization leading to the C2-symmetric octapeptidyl
dilactone core, we synthesized a tetrapeptidyl thioester, 5, as the
native monomer substrate based on a solution-phase procedure
(Figure 3 and Supplemental Data). The C-terminal carboxylic
acid of the peptide chain was condensed with N-acetylcyste-
amine (SNAC), which is a mimic of the phosphopantetheinyl
moiety of the holo-PCP domain. Since substrate 5 contains
a free thiol group, a nonenzymatic thiol/thioester exchange reac-
tion would compete with the desired dimerization and subse-
quent cyclization. A control experiment upon incubation of
5 without Ecm TE resulted in nonenzymatic formation of thioes-
terified and thiolactonized products 14 and 15, respectively
(Figure S3, traces 1A–1C), under reducing conditions in the pres-
ence of 1 mM tris(2-carboxyethyl)phosphine (TCEP) to retain the
thiol in its reduced form (Burns et al., 1991). In consideration of
the competitive reactions, Ecm TE-catalyzed conversion of 5
was conducted under reducing conditions. LC-ESI-MS analysis
revealed the formation of the linear octapeptidyl dimeric product,
7, as well as the desired dilactone, 4 (Figure S3, traces 2A–2C).
The identity of the desired 4, with twin thiol groups, was validated
by comparison with the authentic sample in two ways (Figure S3,
traces 3 and 4). First, the authentic 4 was prepared by reductive
cleavage of the disulfide bond of naturally occurring 2 isolated
from Streptomyces triostinicus (Otsuka et al., 1976). Further-
more, isolation of the resulting dilactone, 4, from the Ecm18–828, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 819
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Enzymatic Macrolactonization with DNAFigure 2. Echinomycin Biosynthesis by Modular Nonribosomal Peptide Synthetases
(A) Modular organization of echinomycin NRPSs. Bars indicate the positions of modules within the protein, whereas individual domains and proteins are shown in
spheres. Ecm1 is quinoxaline-2-carboxylic acid (QC) activating enzyme. FabC is an aryl carrier protein. Ecm6 contains two modules consisting of seven domains.
Ecm7 contains two modules consisting of nine domains, including thioesterase. A, adenylation domain; ArCP, aryl carrier protein; C, condensation domain;
E, epimerization domain; PCP, peptidyl carrier protein; TE, thioesterase domain.
(B) The proposed pathway for echinomycin biosynthesis. QC is transformed from L-tryptophan via a (2S,3S)-b-hydroxyl tryptophan intermediate. QC is activated
by Ecm1 and then tethered to FabC through a phosphopantetheinyl arm. Peptide chain elongation is catalyzed by Ecm6 and Ecm7. The C-terminal TE domain
mediates dimerization and cyclorelease. Subsequent transformations to afford echinomycin (1) through disulfide formation and thioacetalization are mediated by
Ecm17 and Ecm18, respectively.TE-catalyzed reaction mixture and subsequent aerobic oxida-
tion to form a disulfide bridge allowed for the chemoenzymatic
synthesis of 2. These results indicate that Ecm TE can recognize
the native monomer tetrapeptidyl-SNAC substrates and catalyze
dimerization and subsequent lactonization, albeit with low
efficiency.
Ecm TE-Catalyzed Macrolactonization of Octapeptidyl-
SNAC Substrates to Produce Triostin A Analogs
To evaluate the activity of Ecm TE in catalyzing macrolactoniza-
tion, the linear octapeptidyl thioester, 9, was designed (Figure 3).
Substrate 9 contains an ester linkage between D-Ser and L-Val
residues as well as a SNAC thioester at the C terminus. Further-
more, we envisioned chemoenzymatic synthesis of 3by a combi-
nation of solid-phase synthesis of 9 (the tetra-N-demethylated
analog of 7) and enzymatic macrolactonization. First of all, the
octapeptidyl thioester, 9, containing twin thiol groups, was incu-
bated with Ecm TE under reducing conditions in the presence of
TCEP. However, nonenzymatic thiol/thioester exchange reac-820 Chemistry & Biology 15, 818–828, August 25, 2008 ª2008 Elsevtions generated byproducts, and only a trace amount of the
desired dilactone, 11, was detected (data not shown).
To circumvent the experimental difficulties caused by the free
thiol groups, substrate 12, containing a disulfide bond, was syn-
thesized. Inspired by the critical effects of intramolecular back-
bone hydrogen bonds on TE-mediated cyclization (Trauger
et al., 2001), the disulfide bridge of 12 was thought to facilitate
peptide preorganization into a product-like conformation for
macrocyclization. Incubation of 12 with Ecm TE for 8 hr provided
cyclized 3 and hydrolyzed 13 in a 19% and 43% yield, respec-
tively, with a cyclization:hydrolysis ratio of 1:2 (Figure 4A). The
identities of the products were confirmed by LC-MS analysis
(Table S1). The kcat/KM value for cyclization was 0.751 mM
1
min1 (Table 1, entry 1).
Substrate Tolerance of Ecm TE
Having developed a chemoenzymatic protocol to produce
C2-symmetrical cyclic peptides, the substrate tolerance of
Ecm TE was investigated by using nine octapeptidyl-SNACier Ltd All rights reserved
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Enzymatic Macrolactonization with DNAFigure 3. Schematic Presentation of Chemoenzymatic Synthesis of Triostin A and TANDEM by Using Ecm TE
Chemically synthesized peptides 6 and 13 were condensed with N-acetyl cycteamine (SNAC) to produce tetrapeptidyl-SNAC thioester, 5, and
octapeptidyl-SNAC thioester, 12, respectively. Thioester 9, containing two thiols, was synthesized from 12 by reductive cleavage of the disulfide. Aerobic
oxidation of 4 allowed for installation of the disulfide bond, affording 2. Thioester 14 and thiolactone 15 were formed via nonenzymatic thiol/thioester exchange
reactions.thioester analogs, 16–24, with differing amino acid composi-
tions, and their kinetic parameters were compared with those
of 12 (Figure 5 and Figure S4). First, replacement of the L-Cys
residues of 12 into either L-Ala or L-Ser (12/ 16/17) was exam-
ined in order to verify the effects of the disulfide bridge in facili-
tating peptide preorganization into product-like conformations.
As expected, loss of the disulfide bridge reduced the yield of cy-
clic products (Table 1, entries 2 and 3). Second, participation of
the side chain at the position of the L-Ala residues in 12 was in-
vestigated. All changes that include modification of steric factors
(18, 19) as well as installation of hydroxyl groups (20) were found
to hinder enzymatic cyclization (entries 4–6). Next, the L-Val res-
idues of 12were replaced by L-Phe or L-Ala (21 and 22) to assess
the steric influence of an adjacent amino acid side chain in the
substitution of the thioester group. The change to sterically de-
manding L-Phe in 21 had little influence on cyclization (entry 7),
but it led to suppression of hydrolysis. On the other hand, the
presence of the less hindered L-Ala in 22 resulted in acceleration
of enzymatic cyclization by approximately four times (kcat/KM
value) (entry 8), although there was considerable competition
from hydrolysis of the SNAC thioester (Figure 4D[ii]). Finally, an-
alogs 23 and 24, containing twin pyrazine or naphthalene rings,
respectively, in place of the quinoxaline rings, were synthesized
to investigate substrate tolerance at the aromatic rings (entries
9 and 10). Whereas Ecm TE-catalyzed cyclization of 23 resulted
in slow conversion (kcat/KM = 0.046 mM
1 min1), 24 exhibitedChemistry & Biology 15, 85-fold higher reactivity (kcat/KM = 3.87 mM1min1) than 12
(kcat/KM = 0.751 mM
1 min1). These results indicate that the
presence of nitrogen atoms in the chromophore is not essential,
but the ring size of the chromophore plays an important role in
molecular recognition by Ecm TE.
Time Course of Ecm TE-Catalyzed Conversion
of Octapeptidyl-SNAC Substrate 12
As described above, enzymatic cyclization of a variety of
octapeptidyl-SNAC substrates was realized. However, Ecm
TE-mediated conversions in vitro inevitably entailed hydrolysis,
producing carboxylic acids. In an attempt to analyze the reaction
profile of Ecm TE-mediated conversion of 12, the proportions
of substrate 12, the cyclized product 3, and the hydrolyzed
products 13 and 25 were monitored during the course of the
reaction (Figure 4B). The proportion of the desired product, 3,
was increased at the initial stage of the reaction and reached
a maximum of 23% after 5 hr. However, the yield of 3 was then
decreased to 12% after 12 hr. In contrast, the amount of carb-
oxylic acid 13, formed by the hydrolysis of the thioester group
of 12, increased proportionally to 25% and 56% at 5 hr and
12 hr, respectively. These results indicated that product inhibi-
tion and Ecm TE-mediated hydrolysis of 3 are possible major
obstacles in the production of dilactone 3. Besides hydrolysis
of the thioester to yield 13, a small quantity of 25 was formed
by hydrolysis of the ester group of 12.18–828, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 821
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Enzymatic Macrolactonization with DNAFigure 4. Cyclization of Octapeptidyl-SNAC Substrates Mediated by Ecm TE
(A) HPLC traces of reactions (after 8 hr) with initial contents of 5 mM Ecm TE, 25 mM 12, 25 mM HEPES (pH 7.5, 24C), <1% DMSO. Trace 1: negative control
without enzyme. Trace 2: conversion of 12 by Ecm TE without DNA. Trace 3: coincubation with 25 mM DNA (50-GATATCGATATC-30 ).
(B) Time course of Ecm TE-mediated conversion of substrate 12 in the absence of DNA. The chemical structure of 25, formed by hydrolysis of the ester group, is
shown in Figure 6.
(C) Time course of Ecm TE-mediated conversion of 12 in the presence of DNA.
(D) HPLC traces from Ecm TE-mediated conversion of various peptide analogs in the presence of 25 mM DNA. Trace 1: negative control without enzyme. (i) In-
cubation of 18 with Ecm TE for 8 hr at 24C and pH 7.5 in the absence (Trace 2) or presence (Trace 3) of DNA. (ii) Incubation of 22with Ecm TE for 2 hr at 24C and
pH 7.0 in the absence (Trace 2) or presence (Trace 3) of DNA. (iii) Incubation of 24 with Ecm TE for 2 hr at 24C and pH 7.5 in the absence (Trace 2) or presence
(Trace 3) of DNA. Su, substrate; Hy, thioester-hydrolyzed product; Cy, cyclized product.Improvements of Ecm TE-CatalyzedMacrolactonization
Exploiting the DNA-Binding Abilities of Cyclic Peptides
It has been reported that recombinant TEs are inhibited by cyclic
products and also cause the hydrolysis of cyclized products
(Grunewald et al., 2004; Tseng et al., 2002). The addition of
detergent (Yeh et al., 2004) and the use of the organic solvent
(Wagner et al., 2006) have been carried out in an attempt to en-
hance cyclic product formation. In this study, we focused on the
DNA-intercalating properties of the cyclized product 3 and de-
vised an alternative approach involving the use of DNA. TANDEM
3 is known as a synthetic DNA-intercalating agent and shows
a preference for 50-TA steps, particularly 50-ATAT (Lavesa and
Fox, 2001). We thus envisioned that capture of the cyclic product
by DNA containing ATAT sequences could prevent hydrolysis as822 Chemistry & Biology 15, 818–828, August 25, 2008 ª2008 Elsevwell as product inhibition and thereby enhance the enzymatic
production of cyclic 3 (Figure 6). In fact, conversion of 12
(25 mM) by 5 mM Ecm TE in the presence of DNA (25 mM; se-
quence: 50-GATATCGATATC-30; the underlined sequences rep-
resent the DNA-binding sites of TANDEM) proceeded success-
fully to afford the cyclic product 3 in 67% yield with substantial
suppression of hydrolysis (13: 4% yield) after 8 hr of incubation
(Figure 4A, trace 3). Whereas the cyclization:hydrolysis ratio in
the absence of DNA was 1:2, the addition of the DNA dramati-
cally reversed the ratio to 18:1 and significantly enhanced pro-
duction of the cyclic product (19%/ 67% yield).
Next, the time course of the reaction in the presence of DNA
was monitored (Figure 4C). The cyclized product was formed
in 52% and 75% yield after incubation for 5 hr and 12 hr,ier Ltd All rights reserved
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was suppressed considerably to 3% and 4% after incubation for
5 hr and 12 hr, respectively. Furthermore, upon incubation for
12 hr, substrate 12 was almost entirely consumed (recovered
12: <6%), whereas, in the absence of DNA, more than 18% of 12
remained (Figure 4B). In an attempt to verify the critical role
of DNA in Ecm TE-catalyzed conversions, DMSO, a conventional
DNA-denaturing agent, was added to the above-described reac-
tion cocktail (5% v/v), and this was found to abolish the effects
of DNA on Ecm TE-catalyzed conversion (data not shown). In
addition to this, coincubation of DNA (50-AACGTGCACGTT-30)
without the specific binding site (50-ATAT-30) of TANDEM 3 failed
to bring about the positive effects of DNA on the macrolactoniza-
tion and resulted in the formation of a significant amount of the
hydrolyzed product 13 (Figure S5). Thus, these experimentations
demonstrated the importance of the sequence-specific interac-
tion between the cyclic product 3 and DNA.
Based on these encouraging results, nine peptidyl-SNAC
analogs, 16–24, were subjected to Ecm TE-mediated cyclization
in the presence of DNA. No information on the DNA-binding
properties of the cyclic products of these analogs had been
available until we carried out the enzymatic conversions. Im-
provement of enzymatic cyclization by the addition of DNA
would indicate that the resulting cyclic peptide had DNA-interca-
lating activity. Out of the ten octapeptidyl-SNAC substrates
tested, in six cases, including 16–17, 19–21, and 23, the addition
of DNA did not cause a substantial change in the production of
the cyclic product. However, for three analogs, 18, 22, and 24,
the presence of DNA resulted in an increase in the yield of the
desired cyclic products (18: 8%/ 25%; 22: 3%/ 13%; and
24: 8%/ 58%), as shown in Figure 4D. These results indicate
that the addition of DNA promotes Ecm TE-catalyzed enzymatic
cyclization without loss of enzymatic activity and is applicable to
a variety of substrates.
Binding of Cyclic Peptides to DNA with Bisintercalation
To substantiate the effects of DNA on Ecm TE-mediated cycliza-
tion, the interaction between DNA and cyclic peptides was
Table 1. kcat/KM Values for Cyclization with Ecm TE
Entry Substrate
kcat/KM Cyclization
Values (mM1 min1)
1 12a 0.751 ± 0.150
2 16 0.028 ± 0.003
3 17 0.045 ± 0.002
4 18 0.311 ± 0.080
5 19 0.194 ± 0.036
6 20 0.141 ± 0.008
7 21b 0.647 ± 0.055
8 22b 3.13 ± 0.24
9 23 0.046 ± 0.007
10 24 3.87 ± 0.39
a A separate evaluation of kinetic parameters for the cyclization of 12with
Ecm TE was performed to determine the kcat and KM values as 0.0315 ±
0.0053 min1 and 42.2 ± 7.3 mM, respectively.
b Substrates 21 and 22 were incubated at pH 7.0 due to their lability
toward hydrolysis, whereas the other reactions were conducted at pH 7.5.Chemistry & Biology 15, 8verified based on the ability of the peptides to induce unwinding
of negatively supercoiled DNA (Boger et al., 1996, 2001; Huang
et al., 1982) (Figure S6). The unwinding of DNA by echinomycin,
1, was carried out as a positive control, as it was previously re-
ported that the addition of 1 gradually decreased the agarose
gel electrophoresis mobility of supercoiledVX174 DNA (unwind-
ing) at increasing concentrations, followed by a return to normal
mobility (rewinding) at even higher concentrations. When the
experiment was carried out with TANDEM 3 and its analogs, cy-
clized products of 18 and 24, which were obtained in improved
yields by the addition of DNA, the mobility of VX174 DNA was
reduced in a dose-dependent manner, as expected, although
changes indicating conversion to unwinding/rewinding states
were not observed. However, the linear octapeptidyl-SNAC thio-
ester, 12, as well as the cyclized product of 22 did not induce
apparent changes in DNA mobility. Interestingly, the DNA-bind-
ing abilities correlate with the yields of the cyclized products in
the presence of DNA. Thus, these results substantiate the finding
that DNA can selectively capture cyclized products via bisinter-
calation in the presence of its linear octapeptidyl-SNAC thioester
precursor.
DISCUSSION
Recently, the chemoenzymatic construction of macrocyclic
skeletons by using a variety of TE domains has been investigated
for the synthesis of complex natural products and its analogs
(Kohli and Walsh, 2003; Kohli et al., 2002). In the biosynthesis
of the antitumor antibiotic echinomycin, the modular NRPSs
Ecm6 and Ecm7 mediate the formation of the first tetrapeptide
on the PCP domain of Ecm7 (Figure 2), and the C-terminal TE do-
main awaits the assembly of the second tetrapeptide and cata-
lyzes dimerization and subsequent macrolactonization to liber-
ate the C2-symmetric cyclic depsipeptide (Kohli and Walsh,
2003; Shaw-Reid et al., 1999; Hoyer et al., 2007). Here, we pres-
ent chemoenzymatic syntheses of triostin A, 2, and its analogs, in
which peptidyl-SNAC thioesters were prepared by chemical
synthesis in place of the modular NRPSs (Ecm6 and Ecm7)
and were then treated with the excised Ecm TE domain in vitro
to cause dimerization and subsequent macrolactonization.
First of all, tetrapeptidyl thioester, 5, which contains a free
thiol, was synthesized and subjected to conversion mediated
by excised Ecm TE under reducing conditions to maintain the
thiol groups in their reduced form. Although the nonenzymatic
thiol/thioester exchange reaction was predominant, yielding 14
and 15 as the major products, formation of the desired triostin
A precursor, 4, and subsequent aerobic oxidation to form the di-
sulfide bridge allowed for chemoenzymatic synthesis of triostin
A, 2 (Figure 3). Apart from the products of the nonenzymatic
thiol/thioester exchange reactions, dilactone 4 and linear octa-
peptidyl-SNAC ester, 7, were obtained. In addition, hydrolysis
leading to carboxylic acid 6 was observed. These results sug-
gest that intermolecular condensation of the tetrapeptidyl-
O-TE intermediate with free5 is sluggish, and, instead, nucleophilic
attack of a thiol group or a water molecule to the intermediate oc-
cur preferentially. While Ecm TE-mediated dimerization in vitro
relies on intermolecular condensation, the dimerization of tetra-
peptides tethered to PCP and TE domains in vivo can proceed
efficiently. It is important to note that the NRPS (Ecm7)18–828, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 823
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Regions highlighted by color represent differences in the substrates with respect to triostin A, 2. Modified amino acid compositions are shown in red, and
N-demethylated amide nitrogens are shown in blue.responsible for echinomycin biosynthesis successfully regulates
chemical reactivity by modulating the effective molarity of the re-
active groups to form ester bond linkages in the presence of free
thiols and a thioester.
Investigation of similar dimerization activity by TE domains has
thus far been limited to GrsB TE, EntD TE, and TyrC TE (Kohli and
Walsh, 2003; Shaw-Reid et al., 1999; Hoyer et al., 2007; Kohli
et al., 2001), and two possible mechanisms, either a forward or
a backward reaction, have been postulated for peptide ligation
by the PCP/TE domains (Hoyer et al., 2007). In the course of
echinomycin biosynthesis, it is quite probable to assume the
two mechanisms for dimerization: (1) nucleophilic attack of the
hydroxyl group of the first TE-bound monomer on the second
monomer presented by the PCP domain led to a dimer tethered
to the TE domains (forward reaction), or (2) attack of the hydroxyl
group of the second PCP-bound monomer on the first TE-bound
monomer, forming a PCP-bound dimer that is subsequently
transferred to the TE domain for macrolactonization (backward
reaction) (Figure S7). In vitro conversion of tetrapeptidyl thio-
ester, 5, by Ecm TE revealed formation of the octapeptidyl-
SNAC thioester, 7 (Figure S3). Given that 7 is equivalent to the
PCP-bound intermediate of the backward reaction (Figure S7),
it may be presumed that the formation of 7 is consistent with
the ‘‘backward’’ mechanism. On the contrary, it is also probable
that 7 could be a dead-end product, and an actual intermediate
merely accumulates. To verify the intermediary of 7 in the course
of the backward reaction, we intended to conduct Ecm TE-
mediated conversion of 7. However, the fragile nature of 7824 Chemistry & Biology 15, 818–828, August 25, 2008 ª2008 Elsevpossessing two disulfides and a thioester in the same molecule
precluded isolation and further investigations. Alternatively, a
tetra-N-demethyl analog of the PCP-bound intermediate for
the backward reaction was then envisaged. In fact, Ecm TE-
catalyzed macrolactonizations of octapeptidyl thioester analogs
such as 12 have been demonstrated (Table 1). Although it re-
quires further investigations at this stage, these findings are
compatible with the ‘‘backward’’ mechanism, affording an
octapeptidyl thioester intermediate in the biosynthesis of the
depsipeptide core of echinomycin, 1, and triostin A, 2.
Aside from the mechanistic insights into peptide ligation by
NRPSs, chemoenzymatic cyclization of linear octapeptidyl thio-
esters by excised Ecm TE to produce TANDEM 3 and its analogs
was then investigated. First, cyclization by Ecm TE of the linear
octapeptidyl-SNAC, 9, which contains twin thiol groups, was
examined. However, only a trace amount of the desired depsi-
peptide, 4, was obtained (data not shown). In an attempt to im-
prove the enzymatic cyclization, we then designed substrate
12, which has a disulfide bridge that was expected to restrict
the flexibility of the chain and thereby facilitate preorganization
of the substrate, with close proximity of the terminal thioester
and the D-Ser hydroxyl groups as well as the appropriate orien-
tation for macrolactonization. In a similar fashion, a model for
substrate recognition by TycC TE, in which product-like intramo-
lecular backbone hydrogen bonds facilitate preorganization of
the peptide chain for cyclization, has been postulated (Trauger
et al., 2001). Installation of the disulfide bridge was also intended
to protect the nucleophilic thiol groups to prevent undesiredier Ltd All rights reserved
Chemistry & Biology
Enzymatic Macrolactonization with DNAFigure 6. Ecm TE-Catalyzed Macrocyclization in the Presence of DNA Leading to TANDEM
(A) A diagram demonstrating the effect of DNA on the conversion of 12 by Ecm TE. Bold arrows (blue) indicate the major pathways. Upon incubation of 12 with
Ecm TE for 8 hr, the results shown in green (without DNA) and red (with DNA) were obtained. In the absence of DNA, the cyclic product 3was obtained in low yield
(19%), and, instead, a significant amount of 13 (43%) was formed. Hydrolysis of 3 is assumed to be a major pathway to 13. In the presence of DNA, the yield of
cyclized 3 was dramatically improved, to 67%. Since the desired product, 3, can be captured by DNA through bisintercalation, hydrolysis of 3 to give 13 was
almost completely suppressed. In both cases, small quantities of 25 were formed by ester hydrolysis of 12.
(B) Comparison of synthetic approaches to TANDEM 3. Yields for macrocyclization to form the octapeptidyl cyclic skeleton are shown in parentheses. The four
potential sites for macrocyclization, A–D, are shown in red. Protecting groups in the synthetic intermediate 26 for the total synthesis of 3 are shown in blue.thiol/thioester exchanges. Ecm TE-catalyzed cyclization of 12
was carried out, producing the desired TANDEM 3 in 19% yield
after 8 hr of incubation. However, a considerable amount of
carboxylic acid 13 was obtained (43% yield) via hydrolysis of
the thioester group.
Based on reaction monitoring, we deduced two obstacles for
enzymatic production of the cyclic product 3: product inhibition
of Ecm TE, and hydrolysis of 3, causing ring opening to yield 13.
To overcome these obstacles, we focused our attention on the
DNA-binding ability of TANDEM 3 via bisintercalation and envi-
sioned the addition of DNA containing TANDEM-binding se-
quences (50-ATAT-30) in order to capture the cyclic product 3Chemistry & Biology 15, 8(Figure 6A). Gratifyingly, the addition of DNA with two such
binding sites (50-GATATCGATATC-30) resulted in a dramatic
improvement in the yield of the cyclic product 3 (19% /
67%), with a complete reversal of the cyclization:hydrolysis ratio
(1:2/18:1) after 8 hr of incubation. Furthermore, coincubation of
DNA increased consumption of substrate 12 (76% / 87%).
Thus, the improvement in the reaction yield with the addition
of DNA, which captures the cyclic product 3 detaching from
Ecm TE, can be explained by prevention of product inhibition
as well as by hydrolysis of the cyclic product. It is also worth
mentioning that inhibition of Ecm TE by DNA has not been
observed.18–828, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 825
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Enzymatic Macrolactonization with DNAAs mentioned above, the hydrolysis of substrates and cyclized
products generally competes with the desired cyclization and
often constitutes a major obstacle for enzymatic conversion of
nonnatural substrates. To shift the cyclization:hydrolysis ratio
in favor of cyclization, modifications such as the addition of non-
ionic detergent (Yeh et al., 2004) and the use of DMF as a solvent
(Wagner et al., 2006) have been reported. The reported ap-
proaches aim to provide a hydrophobic environment that
prevents nucleophilic attack of a water molecule on the acyl-
enzyme intermediate by embedding the excised TE domain
either in detergent micelles or an aprotic organic solvent. Thus,
the approach described herein, which exploits the DNA-binding
ability of the cyclic products, provides a hitherto unexplored, to
our knowledge, protocol for improvement of TE-catalyzed cycli-
zation. Furthermore, in vitro enzymatic synthesis, which makes
use of DNA to exclude the cyclic products released from the
enzymatic machinery, is strategically analogous to bacterial bio-
synthesis in vivo, which uses transmembrane transporters to
pump out antibiotics before they accumulate to harmful concen-
trations within a producing cell (Walsh, 2003). According to
recent genetic analysis, biosynthetic gene clusters for quinoxa-
line/quinoline antibiotics contain genes that encode ABC trans-
porters for transmembrane secretion systems in this class of
compounds, such as thiocoraline (Lombo et al., 2006).
Next, the applicability of the DNA coexistent protocol was
investigated in the conversion of synthetic substrates 16–24.
Whereas the addition of DNA had a negligible effect on the con-
version of substrates 16–17, 19–21, and 23, the yields of cyclic
products in the conversions of substrates 18, 22, and 24 were
improved by a factor of 3–5. Furthermore, the DNA-binding abil-
ities of 3 and the cyclic products of 18 and 24 were confirmed by
induction of unwinding in supercoiled DNA based on agarose gel
electrophoresis mobility (Figure S4). Thus, the DNA coexistent
protocol was demonstrated to be applicable to TE domain-cat-
alyzed conversion of a variety of synthetic substrates. Further-
more, this protocol represents an attractive possibility for the
screening of DNA-binding small molecules. In the presence of
DNA possessing any type of targeted sequence of small-mole-
cule binding sites in TE-catalyzed cyclization, the production of
DNA-binding cyclic peptides and the primary screening of their
DNA-binding ability could be carried out simultaneously.
Finally, the features of previous syntheses of TANDEM 3 were
compared with the present chemoenzymatic synthesis. The pri-
mary task in the successful synthesis of 3 is ring closure leading
to a macrocyclic skeleton at the final stage of the synthesis. As
shown in Figure 6B, there are four potential sites (A–D) for macro-
cyclization. Lactonization at site A is identical to the mode of ring
closure in the biosynthesis of triostin A, 2. However, this type of
macrocyclization, with the formation of an ester linkage, has
never been reported, presumably due to the poor nucleophilicity
of an alcohol of the D-Ser residue. Boger and coworkers re-
ported macrolactamization at site A to afford an aza analog of tri-
ostin A by replacing the D-Ser with D-b-aminoalanine, providing
an amide versus ester linkage in the cyclic peptide skeleton (Bo-
ger and Lee, 2000). On the other hand, macrolactamization at
site B has been avoided thus far, because the C-terminal L-Cys
residue with a variety of protecting groups has been shown to
undergo racemization upon anchoring as an ester during peptide
elongation (Fujiwara et al., 1994; Han et al., 1997). Malkinson and826 Chemistry & Biology 15, 818–828, August 25, 2008 ª2008 ElseSearcey reported macrolactamization at site C to afford triostin
A, 2 (Malkinson et al., 2005). However, cyclization of the sub-
strate without protecting groups to afford 2 directly resulted in
a low yield (11%). This mode of cyclization (site C) showed an im-
proved yield of up to 59% with the use of a protected substrate
with a Cbz group for D-Ser and an Asm group for the thiol. In turn,
Diederichsen reported condensation of Cbz-protected C-termi-
nal D-Ser with an L-Ala residue to allow for macrolactamization
at site D, yielding the protected 26 in 86% yield (Lorenz and Die-
derichsen, 2004). Thus, chemical approaches have necessitated
protecting groups for efficient construction of the macrocyclic
skeleton, and, consequently, additional protecting group manip-
ulations are required to afford the desired 3. In contrast, the
chemoenzymatic approach described herein allows for direct
conversion of thioester 12 to 3 in satisfactory yields (67% for
a 8 hr incubation; 74% for a 10 hr incubation) without racemiza-
tion. Thus, we have developed a straightforward synthetic route
to TANDEM 3 and its analogs by harnessing the potential of
excised TE-catalyzed macrolactonization.
SIGNIFICANCE
The C-terminal TE domain of modular NRPS allows for site-
selectivemacrocyclization in the presence ofmultiple nucle-
ophiles without the use of protecting groups, producing
cyclic peptides with a diverse array of functional groups
linked to the constrained skeletons. We showed that the re-
combinant Ecm TE domain can catalyze dimerization and
subsequent lactonization in vitro to form the C2-symmetric
octadepsipeptide core of triostin A. Conversions of peptidyl
thioesters with free thiol groups provide insight into the key
role of the Ecm TE, which catalyzes the formation of ester
linkages by activating hydroxyl groups in the presence of
intrinsically more nucleophilic thiol groups, precluding thiol/
thioester exchange reactions. In an effort to achieve chemo-
enzymatic synthesis of the synthetic derivative TANDEM
and its analogs, substrate preorganization into product-
like conformations by installation of a disulfide bridge was
shown to be critical for Ecm TE-catalyzed cyclization.
More importantly, coincubation with DNA successfully sup-
pressed undesired hydrolysis as well as product inhibition,
and it resulted in a remarkable improvement in the yield of
cyclized products (greater than three-fold improvement:
19%/ 67%). In vitro enzymatic synthesis employing DNA
to capture and thereby exclude the cyclic product from the
active site of the biosynthetic enzyme has a tactical analogy
with in vivo bacterial biosynthesis that uses transmembrane
transporters to pump out antibiotics. This chemoenzymatic
strategy making use of DNA will be useful for other quinoxa-
line/quinoline antibiotics and will also be generally applica-
ble to small molecules with DNA-binding properties.
EXPERIMENTAL PROCEDURES
Cloning and Expression of the Ecm TE Domain
The echinomycin gene fragment encoding Ecm TE was amplified by PCR from
cosCD4 (containing the echinomycin biosynthetic gene cluster) by using
SP-Taq DNA polymerase (Cosmo Genetech) with the following oligonucleo-
tides: forward primer 50-ATACATATGGACACCGACGCCCAGTTCGA-30, re-
verse primer 50-AAAAAGCTTCTGCGACGCCCGCAGCATGC-30. The amplifiedvier Ltd All rights reserved
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vector system (Promega). The resulting plasmid was digested with the restric-
tion enzymes Nde_ and BamH_. The digested DNA fragment was ligated into
the Nde_/BamH_ site of a pET22b (Novagen) by using DNA ligation kit ver.
2.1 (Takara). The construct (pET22b-ecmTE) was confirmed by sequencing
with an ABI prism 310 genetic analyzer (Applied Biosystems). For expression,
the pET22b-ecmTE was transformed into E. coli BL21(DE3). The transformed
cells were grown at 37C to OD = 0.6 (600 nm) and then induced with 0.4 mM
IPTG. After additional incubation at 24C for 8 hr, the cells were harvested by
centrifugation at 2,5003 g for 15 min and resuspended in the disruption buffer
(0.1 M Tris-HCl, 0.3 M NaCl, 10 mM imidazole, 10 mM MgCl2, 10% v/v glycerol
[pH 7.2]). Treatment with 1 mg/ml lysozyme for 5 min on ice and subsequent
sonication disrupted the cells. The insoluble residues were removed by centri-
fugation at 18,6003 g for 30 min, and the supernatant protein was purified by
Ni-NTA affinity chromatography (GE Healthcare). Buffer exchange into the re-
action buffer (25 mM HEPES, 50 mM NaCl [pH 7.5]) was carried out by using
a PD-10 column (GE Healthcare). Protein purity was confirmed by SDS-
PAGE analysis to be greater than 95% (Figure S2). The protein concentration
was estimated by using the Bradford assay for the BSA standard. The purified
protein was flash frozen in liquid nitrogen and stored at 80C for several
months without significant loss of activity.
Solid-Phase Synthesis of Linear Peptides
Peptides were synthesized manually by using a stepwise solid-phase proce-
dure (Figure S8). Protected amino acids and reagents were purchased from
Watanabe Chemical Industries, Novabiochem, and Wako Pure Chemical
Industries. All peptide couplings were carried out for 30 min in DMF by using
a 5 equiv. (over resin loading) of a protected amino acid activated with
HBTU (5 equiv.) and HOBt (5 equiv.) in the presence of i-Pr2NEt (10 equiv.).
Each coupling reaction was repeated, and completion was detected by using
the Kaiser test for free amines. If coupling was not completed, the reaction was
further repeated until a negative Kaiser test was obtained. N-Fmoc protection
was removed by using 20% (v/v) piperidine in DMF (2 3 10 min). The o-trityl
group of the D-Ser side chain was cleaved by exposure to 2% (v/v) TFA in
dry CH2Cl2 containing 5% (v/v) i-Pr3SiH (3 3 5 min; 13 20 min). Esterification
of the free hydroxyl group of D-Ser was performed in DMF by using N-Fmoc-
Val (5 equiv.) and N,N0-diisopropylcarbodiimide (DIC: 5 equiv.) in the presence
of a catalytic amount (10 mol%) of 4-dimethylaminopyridine (2 3 1.5 hr).
S-Acm deprotection and simultaneous disulfide-bond formation were effected
on the solid phase by treatment with iodine (10 equiv.) in DMF (1 hr), followed
by thorough washing of the resin-bound depsipeptide with copious DMF,
CH2Cl2, and 50% (v/v) MeOH in CH2Cl2, and then drying in vacuo (Malkinson
et al., 2005). The peptides were liberated from the solid support by exposure
with TFA containing 2.5% (v/v) water and 2.5% (v/v) i-Pr3SiH for 2 hr at
25C. After removal of TFA under reduced pressure, the crude peptides
were precipitated in cold anhydrous Et2O and centrifuged. The precipitates
were washed with cold anhydrous Et2O, dried in vacuo, and used without
further purification.
Synthesis of Peptidyl-SNAC Thioester Substrates
The mixture of the crude peptide-N-acetylcysteamine (5 equiv.), PyBOP
(3 equiv.), i-Pr2NEt (3 equiv.) in THF/DMF (4:1) was stirred for 30 min at 20C
and then warmed up to room temperature. After being stirred for an additional
3 hr, the mixture was concentrated in vacuo. The residues were purified by
high-performance liquid chromatography (HPLC) on a LC-10AD vp HPLC
system (Shimadzu) with a Wakosil-II 5C18 column (Wako Pure Chemical
Industries). The fractions were lyophilized to dryness and then dissolved in
DMSO. The identities of the peptidyl-SNAC substrates were verified by
LC-ESI-MS (LC: Agilent 1100 system, MS: JEOL, JMS-T100LP AccuTOF
LC-plus) with a Zorbax Eclipse XDB-C18 column (Agilent, 50/2.1, particle
size of 5 mm) (Table S1).
Ecm TE-Catalyzed Dimerization and Lactonization
of Tetrapeptidyl-SNAC Substrate 5
Enzymatic reactions were carried out in a buffer solution (25 mM HEPES,
50 mM NaCl, 1 mM TCEP [pH 7.5]) at 24C in a total volume of 25 ml. The
reactions were initiated by the addition of enzyme (Ecm TE: 10 mM), with a sub-
strate concentration of 300 mM. After incubation for 2 hr, the reactions wereChemistry & Biology 15, 8quenched by the addition of 5% TFA/CH3CN (5 ml). The reaction products
were analyzed by LC-ESI-MS under the following conditions: 0–5 min, 20%
acetonitrile/0.1% HCOOH in H2O/0.1% HCOOH; 5–25 min, linear gradient
20%–80% acetonitrile/0.1% HCOOH in H2O/0.1% HCOOH. The cyclized
product 4 was separated by HPLC and concentrated to dryness under a
stream of N2. The resulting residue was left aerobically at room temperature
overnight to form a disulfide bond by oxidation. The resulting sample was
analyzed by LC-ESI-MS to confirm the formation of 2.
Ecm TE-Catalyzed Macrolactonization of Octapeptidyl-SNAC
Substrates
Enzymatic reactions were conducted under the same conditions as described
above, except for the total volume (50 ml), the substrate concentration (25 mM),
and the enzyme concentration (Ecm TE: 5 mM). The substrate concentration
was 25 mM for standard reactions and varied in the kinetic experiments. The
reactions were quenched at various times by the addition of 2% TFA/H2O
(50 ml). The reaction products were analyzed by HPLC (Shimadzu) with an
Inertsil ODS-3 column (GL Science, 150/3, pore diameter: 100 A˚, particle
size: 3 mm) under the following conditions: 0–5 min, 30% acetonitrile/0.05%
TFA in H2O/0.05% TFA; 5–35 min, linear gradient 30%–80% acetonitrile/
0.05% TFA in H2O/0.05% TFA; or 0–5 min, 20% acetonitrile/0.05% TFA in
H2O/0.05% TFA; 5–35 min, linear gradient 20%–80% acetonitrile/0.05%
TFA in H2O/0.05% TFA; 0.4 ml/min, 45
C. The extinction coefficients at
245 nm and 325 nm (the absorption maximum of the quinoxaline rings) were
assumed to be the same for the substrates and products. The identities of
the products were confirmed by LC-ESI-MS analysis (Table S1).
Ecm TE-Catalyzed Macrolactonization in the Presence of DNA
The HPLC-purified oligonucleotide (50-GATATCGATATC-30) was purchased
from Hokkaido System Science and used without further purification. The
underlined sequences represent the sites previously reported to bind with
TANDEM (Lavesa and Fox, 2001). The oligonucleotide was dissolved in the
reaction buffer (25 mM HEPES, 50 mM NaCl [pH 7.5]) as a stock solution. In
the standard reaction, the final concentration of the oligonucleotide was
adjusted to 25 mM. The reactions were conducted under the same conditions
as described above.
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